Sexy Design
True Power
Icon Paradise
Page Builder
Top Quality
Customizable
Hello. We’re Salient, A Creative Agency Located In New York City. Take A Look Around & Don’t Be Shy.
Phasellus enim libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci ut et lobortis aliquam.
Phasellus enim libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci ut et lobortis aliquam.
Phasellus enim libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci ut et lobortis aliquam.
Phasellus enim libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci ut et lobortis aliquam.
We Make Beautiful Things
35
Thousand
Theme Users
It takes a lot to be one of the most trusted themes on the market. Read more below why users keep coming back over and over again.
Unique Design
Take full control of the power Salient has to offer with our new exciting page builder. You’ll be grinning in delight when you see just how easy it is to create stunning layouts with little effort.
Page Builder
Take full control of the power Salient has to offer with our new exciting page builder. You’ll be grinning in delight when you see just how easy it is to create stunning layouts with little effort.
Continual Updates
Take full control of the power Salient has to offer with our new exciting page builder. You’ll be grinning in delight when you see just how easy it is to create stunning layouts with little effort.
Video Tutorials
Take full control of the power Salient has to offer with our new exciting page builder. You’ll be grinning in delight when you see just how easy it is to create stunning layouts with little effort.
Oh, & We Blog Sometimes
에이비온, 교모세포종 치료제 IND 신청 “적응증 확장…기술이전 협상력 강화”
에이비온은 식품의약품안전처에 교모세포종(GBM) 치료제 개발을 위한 '바바메킵(Vabametkib·ABN401)' 임상 2상 시험계획서(IND)를 제출했다고 6일 밝혔다. 이번 임상은…
Read More
에이비온, MFDS 바바메킵 임상 2상 변경 승인 “혁신신약 개발 목표”
에이비온은 바바메킵(Vabametkib·ABN401)의 임상 2상 시험계획 변경에 대해 식품의약품안전처(MFDS)가 승인했다고 17일 밝혔다. 레이저티닙과 바바메킵의 병용 임상으로…
Read More
